Left ventricular hypertro- phy and cardiovascular disease risk prediction and reclassification in blacks and whites: the Atherosclerosis Risk in Communities Study. Am Heart J. 2015;169:155 61. S7.2-23. Zalawadiya SK, Gunasekaran PC, Bavishi CP, et al. Left ventricular hypertrophy and risk reclassification for coronary events in multi- ethnic adults. Eur J Prev Cardiol. 2015;22:673 9. 8. Treatment of High BP 8.1. Pharmacological Treatment 8.1.1. Initiation of Pharmacological BP Treatment in the Context of Overall CVD Risk S8.1.1-1. Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA. 2005;294:466 72. S8.1.1-2. Ozyilmaz A, Bakker SJL, de Zeeuw D, et al. Screening for albu- minuria with subsequent screening for hypertension and hypercho- lesterolaemia identifies subjects in whom treatment is warranted to prevent cardiovascular events. Nephrol Dial Transplant. 2013;28: 2805 15. S8.1.1-3. Peters SAE, Huxley RR, Woodward M. Comparison of the sex- specific associations between systolic blood pressure and the risk of cardiovascular disease: a systematic review and meta-analysis of 124 cohort studies, including 1.2 million individuals. Stroke. 2013;44:2394 401. S8.1.1-4. Schoenfeld SR, Kasturi S, Costenbader KH. The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review. Semin Arthritis Rheum. 2013;43: 77 95. S8.1.1-5. Lawes CMM, Bennett DA, Lewington S, et al. Blood pressure and coronary heart disease: a review of the evidence. Semin Vasc Med. 2002;2:355 68. S8.1.1-6. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903 13. S8.1.1-7. Takashima N, OhkuboT, Miura K, et al. Long-term risk of BP values above normal for cardiovascular mortality: a 24-year observation of Japanese aged 30 to 92 years. J Hypertens. 2012;30:2299 306. S8.1.1-8. 